COMP <GO>
NEPH vs BEAT // NET PROFIT MARGIN
Nephros Inc. (NASDAQ) VS. Heartbeam Inc. (NASDAQ) • 15-METRIC TALLY: NEPH 3
— BEAT 1
■ METRIC PARITY
LAST: $3.27 (+3.16%) • MKT CAP: $35.5M
net-margins
6.40%
LAST: $0.54 (+1.34%) • MKT CAP: $30.4M
net-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEPH VS. BEAT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEPH | BEAT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.90% | -35.00% | +53.90 | NEPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.50% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 6.10% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 6.40% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 32.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | NEPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.5 | 61.7 | -21.20 | BEAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $35.5M | $30.4M | $5.2M | NEPH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEPH REV | BEAT REV | NEPH GROSS % | BEAT GROSS % | NEPH FCF | BEAT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.8M | $0 | 61.9% | — | $1.6M | -$14.6M |
| FY 2024 | $14.2M | $0 | 61.6% | — | -$547.0K | -$14.7M |
| FY 2023 | $14.2M | $0 | — | — | $827.0K | -$12.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEPH // BETA —
BEAT // BETA —